Biosysen is a synthetic biology company focused on species design, and is an alumni company of Sequoia Capital, Sky9 Capital, and MiraclePlus. We aim to unlock the productivity of the bio-industry by using software engineering concepts to guide species design. Biosysen's products are artificial species libraries and related pipelines that meet specific industrial purposes, with a focus on food, medical testing, daily chemicals, and medical protein development. Biosysen's vision is to build a complete biotechnology ecosystem based on artificial species architecture.
